Propanc Biopharma, Inc. (PPCB) Form 10-K Annual Reports
Propanc Biopharma, Inc. (PPCB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PPCB
CIK: 1517681
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Salberg & Company, P.A.
Auditor SinceSince 6/30/2017 12:00:00 AM
Lead Engagement PartnerRyan Barth
Audit LocationBoca Raton, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| PRE 14C | 2026-10-08 | 2026-10-08 | PRE 14C | 0001493152-26-046366 | View SEC Doc Filr Page |
| S-1 | 2026-10-05 | — | S-1 | 0001493152-26-045770 | View SEC Doc Filr Page |
| 10-K | 2026-09-25 | 2026-06-30 | 10-K | 0001493152-26-044373 | View SEC Doc Filr Page |
| DEF 14C | 2026-08-21 | 2026-08-20 | DEF 14C | 0001493152-26-039522 | View SEC Doc Filr Page |
| PRE 14C | 2026-08-05 | 2026-08-04 | PRE 14C | 0001493152-26-036041 | View SEC Doc Filr Page |
| EFFECT | 2026-07-27 | — | EFFECT Filing | 9999999995-26-002465 | View SEC Doc Filr Page |
| S-1 | 2026-07-17 | — | S-1 | 0001493152-26-033807 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-08 | 8-K | 0001493152-26-033173 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001493152-26-023210 | View SEC Doc Filr Page |
| EFFECT | 2026-04-20 | — | EFFECT Filing | 9999999995-26-001258 | View SEC Doc Filr Page |
| CORRESP | 2026-04-16 | — | CORRESP Filing | 0001493152-26-017000 | View SEC Doc Filr Page |
| UPLOAD | 2026-04-15 | — | UPLOAD Filing | 0000000000-26-003828 | View SEC Doc Filr Page |
| S-1 | 2026-04-10 | — | S-1 | 0001493152-26-016228 | View SEC Doc Filr Page |
| DEF 14C | 2026-03-31 | 2026-03-31 | DEF 14C | 0001493152-26-013734 | View SEC Doc Filr Page |
| PRE 14C | 2026-03-20 | 2026-03-19 | PRE 14C | 0001493152-26-011711 | View SEC Doc Filr Page |
| PRE 14A | 2026-03-19 | 2026-03-19 | PRE 14A | 0001493152-26-011697 | View SEC Doc Filr Page |
| 424B3 | 2026-03-06 | — | 424B3 | 0001493152-26-009199 | View SEC Doc Filr Page |
| 8-K | 2026-02-26 | 2026-02-20 | 8-K | 0001493152-26-008196 | View SEC Doc Filr Page |
| EFFECT | 2026-02-24 | — | EFFECT Filing | 9999999995-26-000658 | View SEC Doc Filr Page |
| CORRESP | 2026-02-20 | — | CORRESP Filing | 0001493152-26-007520 | View SEC Doc Filr Page |
| S-1/A | 2026-02-19 | — | S-1/A | 0001493152-26-007492 | View SEC Doc Filr Page |
| 10-Q | 2026-02-17 | 2025-12-31 | 10-Q | 0001493152-26-007052 | View SEC Doc Filr Page |
| CORRESP | 2026-02-12 | — | CORRESP Filing | 0001493152-26-006497 | View SEC Doc Filr Page |
| CORRESP | 2026-02-10 | — | CORRESP Filing | 0001493152-26-006023 | View SEC Doc Filr Page |
| UPLOAD | 2026-02-10 | — | UPLOAD Filing | 0000000000-26-001374 | View SEC Doc Filr Page |